Cross-sectional frequency of solicited, self-reported symptoms suggestive of myo/pericarditis at visits 2 weeks post-vaccination/boost.

a<p>total number of participants who received: MVA = 382; placebo = 43.</p>b<p>expressed in mean ± standard deviation; for participants who had multiple reports of a given symptom, the minimum number of days post-vaccination and maximum duration of symptoms were used.</p>c<p>palpitations and flu-like symptoms not collected for SLU-DMID study.</p><p>n/a = not applicable.